Doctor of Optometry Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Steven Giang

Optometrist San Diego, CA Doctor of Optometry

NPI 1730710104 CMS profile 8612692

3434 4Th Ave, San Diego, CA 92103

Open in the dashboard

General payments

$6,130

128 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Steven Giang of San Diego, CA is reported in the CMS Open Payments database as having received $6,130 across 128 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $173 6
2024 General $1,403 38
2023 General $1,218 23
2022 General $1,117 27
2021 General $1,687 21
2020 General $532 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Giang
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Steven Giang were reported at $173. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Steven Giang Optometrist median Middle half National median
2019 $0 $159 $67–$371 $163
2020 $532 $72 $29–$165 $114
2021 $1,687 $125 $46–$292 $132
2022 $1,117 $162 $66–$374 $149
2023 $1,218 $177 $72–$406 $160
2024 $1,403 $188 $77–$427 $164
2025 $173 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Bausch & Lomb Americas Inc. $1,432 30 payments
  2. Alcon Vision LLC $1,096 19 payments
  3. Bausch & Lomb, a division of Bausch Health US, LLC $1,011 18 payments
  4. AbbVie, Inc. $594 24 payments
  5. CooperVision Inc. $451 7 payments
  6. Optos, Inc. $342 4 payments
  7. Mallinckrodt Hospital Products Inc. $215 7 payments
  8. Glaukos Corporation $181 3 payments
  9. Sun Pharmaceutical Industries Inc. $149 3 payments
  10. LKC Technologies, Inc. $126 1 payment
  11. Other $533 12 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $5,848 123 payments
  2. Entertainment $244 3 payments
  3. Gift $39 2 payments
Products named General payments · program years 2020–2025
  1. INFUSE $1,753 25 payments
  2. MyDay Contact Lens $394 5 payments
  3. OCT OPHTHALMOSCOPE Ophthalmology $342 4 payments
  4. PANORAMIC OPHTHALMOSCOPE Ophthalmology $342 4 payments
  5. PANORAMIC OPHTHALMOSCOPE Ophthalmology $342 4 payments
  6. BIOTRUE $258 9 payments
  7. OCT OPHTHALMOSCOPE Ophthalmology $244 3 payments
  8. NFC-700 $244 3 payments
  9. ULTRA MULTIFOCAL TORIC $243 2 payments
  10. TOTAL30 $236 6 payments
  11. Other $3,532 99 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

128 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record